http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 18 Aug 2026 17:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orthofix+Medical+Inc.+++++For%3A+Aug+14++Filed+by%3A+Juniper+Investment+Company%2C+LLC/26945305.html si-local-file:///var/storage/secattach/20260818/26945305.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orthofix+Medical+Inc.+++++For%3A+Aug+14++Filed+by%3A+Juniper+Investment+Company%2C+LLC/26945305.html Tue, 18 Aug 2026 17:05:00 -0400 O.00811666 OFIX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orthofix+Medical+Inc.+++++For%3A+Aug+14++Filed+by%3A+Juniper+Investment+Company%2C+LLC/26945305.html si-local-file:///var/storage/secattach/20260818/26945305.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Orthofix+Medical+Inc.+++++For%3A+Aug+14++Filed+by%3A+Juniper+Investment+Company%2C+LLC/26945305.html Tue, 18 Aug 2026 17:05:00 -0400 O.00811666 OFIX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Orthofix+Medical+Inc.++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26926353.html si-local-file:///var/storage/secattach/20260814/26926353.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Orthofix+Medical+Inc.++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26926353.html Fri, 14 Aug 2026 10:23:00 -0400 O.00811666 OFIX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Orthofix+Medical+Inc.++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26926353.html si-local-file:///var/storage/secattach/20260814/26926353.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Orthofix+Medical+Inc.++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/26926353.html Fri, 14 Aug 2026 10:23:00 -0400 O.00811666 OFIX http://www.streetinsider.com/Analyst+PT+Change/Orthofix+Medical+%28OFIX%29+PT+Lowered+to+%2413+at+Canaccord/26894093.html Canaccord analyst Caitlin Burrows lowered the price target on Orthofix Medical (NASDAQ: OFIX) to $13.00 (from $18.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Orthofix+Medical+%28OFIX%29+PT+Lowered+to+%2413+at+Canaccord/26894093.html Mon, 10 Aug 2026 07:00:59 -0400 OFIX http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Orthofix+Medical+Inc.++++++++++++++++/26874118.html si-local-file:///var/storage/secattach/20260805/26874118.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Orthofix+Medical+Inc.++++++++++++++++/26874118.html Wed, 05 Aug 2026 16:08:00 -0400 O.00811666 OFIX http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Orthofix+Medical+Inc.++++++++++++++++/26874118.html si-local-file:///var/storage/secattach/20260805/26874118.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Orthofix+Medical+Inc.++++++++++++++++/26874118.html Wed, 05 Aug 2026 16:08:00 -0400 O.00811666 OFIX http://www.streetinsider.com/Analyst+PT+Change/Orthofix+Medical+%28OFIX%29+PT+Lowered+to+%2413+at+Stifel/26873259.html Stifel analyst Thomas M. Stephan lowered the price target on Orthofix Medical (NASDAQ: OFIX) to $13.00 (from $15.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Orthofix+Medical+%28OFIX%29+PT+Lowered+to+%2413+at+Stifel/26873259.html Wed, 05 Aug 2026 15:03:25 -0400 OFIX http://www.streetinsider.com/Earnings/Orthofix+International+%28OFIX%29+Tops+Q2+EPS+by+1c%3B+Offers+Guidance/26871249.html <p>Orthofix International (NASDAQ: OFIX) reported Q2 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $210.93 million versus the consensus estimate of $209.28 million.</p><p>FY2026 Outlook-</p><p>Revenue between $845 million to $855 million versus the consensus $843.3 million.</p><p>For earnings history and earnings-related data on Orthofix International (OFIX) <a href="http://www.streetinsider.com/ec_earnings.php?q=OFIX">click here</a>.</p> http://www.streetinsider.com/Earnings/Orthofix+International+%28OFIX%29+Tops+Q2+EPS+by+1c%3B+Offers+Guidance/26871249.html Wed, 05 Aug 2026 09:01:32 -0400 OFIX http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Orthofix+Medical+Inc.+++++For%3A+Jun+30/26870154.html si-local-file:///var/storage/secattach/20260805/26870154.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Orthofix+Medical+Inc.+++++For%3A+Jun+30/26870154.html Wed, 05 Aug 2026 07:06:00 -0400 O.00811666 OFIX http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Orthofix+Medical+Inc.+++++For%3A+Jun+30/26870154.html si-local-file:///var/storage/secattach/20260805/26870154.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Orthofix+Medical+Inc.+++++For%3A+Jun+30/26870154.html Wed, 05 Aug 2026 07:06:00 -0400 O.00811666 OFIX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Orthofix+Medical+Inc.+++++For%3A+Aug+05/26870119.html si-local-file:///var/storage/secattach/20260805/26870119.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Orthofix+Medical+Inc.+++++For%3A+Aug+05/26870119.html Wed, 05 Aug 2026 07:04:00 -0400 O.00811666 OFIX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Orthofix+Medical+Inc.+++++For%3A+Aug+05/26870119.html si-local-file:///var/storage/secattach/20260805/26870119.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Orthofix+Medical+Inc.+++++For%3A+Aug+05/26870119.html Wed, 05 Aug 2026 07:04:00 -0400 O.00811666 OFIX http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Press+Releases/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html <p> LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. </p><p> <b>Highlights</b> </p><ul class="bwlistdisc"> <li> <b>Second quarter 2026 reported net sales of $210.9 million, representing an increase of 4% on a reported basis and 5% on a pro forma constant currency basis</b> compared to http://www.streetinsider.com/Business+Wire/Orthofix+Reports+Second+Quarter+2026+Results+Reflecting+Continued+Operational+Progress/26869971.html Wed, 05 Aug 2026 07:00:00 -0400 A.50113897 A.50204774 O.00174975 O.00811666 O.23224651 OFIX